Results 231 to 240 of about 1,460,646 (299)

Lung transplantation from polytrauma donors: beyond primary graft dysfunction. [PDF]

open access: yesFront Med (Lausanne)
Catelli C   +12 more
europepmc   +1 more source

Increased Risk of Subsequent Cancers in Patients With Sézary Syndrome

open access: yes
American Journal of Hematology, EarlyView.
Julia Nenonen   +3 more
wiley   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

Lung transplantation in 2025: a narrative review of progress, challenges, and the road ahead. [PDF]

open access: yesJ Thorac Dis
Jin X   +13 more
europepmc   +1 more source

Comparative Transcriptional Profiling of Key Macrophage and Fibroblast Subpopulations in Rheumatoid Arthritis–Associated Lung Disease

open access: yesArthritis &Rheumatology, EarlyView.
Objective Rheumatoid arthritis (RA) often involves extra‐articular complications, including interstitial lung disease (ILD) and/or pulmonary nodules. Transcriptomic profiling of lung tissue provides the opportunity to directly assess cell‐specific gene expression and corresponding pathway activation in different types of rheumatoid lung disease ...
Tracy Tabib   +8 more
wiley   +1 more source

Lung transplantation outcomes in candidates aged ≥ 70 years old: A 10-year single center experience. [PDF]

open access: yesJHLT Open
Aubrey JM   +9 more
europepmc   +1 more source

Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin‐6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective Nonmelanoma skin cancer (NMSC) is one of the most common malignancies in rheumatoid arthritis (RA). This analysis assessed NMSC risk with JAK inhibitors (JAKi) compared to interleukin‐6 receptor inhibitors (IL‐6Ri). Methods This study used data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis linked to the
Zixing Tian   +8 more
wiley   +1 more source

Seeing is believing: Mouse orthotopic vascularized right lung transplantation

open access: yesJHLT Open
Jin Zhao   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy